Market Trends of Veterinary Diagnostics Industry
The Molecular Diagnostics Segment is Estimated to Witness Significant Growth Over the Forecast Period.
The molecular diagnostics segment is expected to witness significant growth over the forecast period due to livestock and pet owners' growing preference for quick test results and their cost-effectiveness. The segmental expansion is anticipated to be driven by the rising number of tests designed to identify prevalent animal diseases such as feline leukemia, canine parvovirus, heartworm, and infectious peritonitis. Furthermore, the increasing number of pet and livestock owners and the growing concern for their animal health, the rise in the prevalence of companion animal and livestock animal diseases, and the accessibility of affordable immunoassay tests that allow for frequent testing at home are also contributing to the growth of this segment.
The increasing cases of avian influenza in livestock animals are boosting the demand for molecular diagnostic tests, thereby driving the growth of this segment. For instance, in April 2022, as per the report published by the Government of Canada, various avian species—turkeys, ducks/chickens, geese, and peafowls—were infected by avian influenza in March 2022. The disease spreads rapidly among all livestock species, thus increasing molecular diagnostic tests for its detection, thereby contributing to the segment's growth.
Similarly, in July 2021, the European Pet Food Federation reported that between March 2020 and March 2021, it was estimated families adopted around 3.2 million pets in Britain. Thus, the high number of pet adoptions in European families is increasing awareness among pet owners about the health of pet animals, which is increasing the demand for Companion Animal Diagnostics, thereby contributing to the growth of this segment.
The launch of instruments and other products by market players is augmenting the market's growth. For instance, in August 2021, HORIBA UK Limited launched several new pathogen PCR tests for its POCKIT Central, an in-house Veterinary PCR System analyzer with the potential for fast, accurate PCR testing in every veterinary lab. Such launches are propelling the growth of the Veterinary Molecular Diagnostics Market.
Furthermore, in January 2022, Ringbio launched a professional website named petrapidtest.com to market Flexy Pet Rapid Test. These kits are based on lateral flow immunoassay, ELISA, and real-time PCR to detect companion animal diseases, which can be helpful for pet owners and vet clinics. Among these products, real-time PCR is specially designed for small vet clinics and can confirm infection of viruses, mycoplasma, and parasites. Such marketing initiatives taken by the players also augment the segment's growth.
Thus, with the increasing cases of avian influenza in livestock animals, increased pet adoption, and new product launches, the Veterinary Molecular Diagnostics Market is expected to show significant growth over the forecast period due to the abovementioned factors.
North America is Expected to Witness a Significant Growth Over the Forecast Period.
The North American region comprises the United States, Canada, and Mexico. The studied market is expected to witness significant growth in the region due to the increasing adoption of pet and livestock animals, availability of better diagnostics facilities, and technological developments due to the presence of key Veterinary Diagnostics Companies.
The increasing trend of livestock adoption also propels the market's growth in the region. For instance, in March 2022, USDA reported that in 2021, Mexico's cattle imports considerably increased. The source also reported a 5.4% growth in Mexico's livestock farming sector in 2021. Thus, the increasing livestock number in Mexico is boosting the Livestock Diagnostics Market, as there is an increasing risk of veterinary diseases, thereby driving the demand for Livestock Diagnosis Market solutions.
Moreover, the growing number of veterinary practitioners is also driving the growth of the studied market. For instance, in September 2022, the US Bureau of Labor Statistics reported that employment of veterinarians is projected to grow 19% from 2021 to 2031, much faster than the average for all occupations. Also, the same source reported that about 4,800 openings for veterinarians are projected each year, on average, over the decade. Thus, the increasing number of veterinary practitioners is leading to increased Veterinary Diagnostic Services, thereby driving the growth of the Veterinary Diagnostics Market.
The development of preventive diagnostic tools also contributes to the increasing number of veterinary visits and preventive care. For instance, in April 2021, Antech Diagnostics, a part of Mars Veterinary Health, released new data showing that all cats from a retrospective review of 730,000 veterinary visits received improved preventive care following a positive or negative RenalTech. RenalTech predicts CKD in cats two years before it occurs. The data shows that the predictive diagnostic tool increased veterinary visits by as much as 31%. Such studies and the development of predictive diagnostics tools are also driving the market growth in the country.
The increasing number of launches of diagnostic tests by market players is also propelling the market's growth. For instance, in July 2021, Vidium Animal Health launched SpotLight ePARR. It is a highly accurate and rapid molecular diagnostic test for canine lymphoma. Vidium developed it in collaboration with the Translational Genomics Research Institute (TGen), an affiliate of the City of Hope, and Ethos Discovery. Such advancements are strengthening the Veterinary Diagnostics Market in North America.
Thus, due to the increasing adoption of pet and livestock animals, availability of better diagnostics facilities, and technological developments, North America is expected to project significant growth over the forecast period.
